Prosecution Insights
Last updated: April 19, 2026

Examiner: VU, QUYNH-NHU HOANG

Tech Center 3700 • Art Units: 3763 3783

This examiner grants 68% of resolved cases

Performance Statistics

68.0%
Allow Rate
-2.0% vs TC avg
1029
Total Applications
+28.1%
Interview Lift
1267
Avg Prosecution Days
Based on 971 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
21.6%
§102 Novelty
41.4%
§103 Obviousness
27.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18535032 Infusion Pump Apparatus, Method and System Final Rejection DEKA Products Limited Partnership
17035536 Devices, Methods and Systems for Wireless Control of Medical Devices Final Rejection DEKA Products Limited Partnership
18164708 DRIVE DEVICE INCLUDING FLEXIBLE PLUNGER SHAFT Non-Final OA INSULET CORPORATION
17930347 CLUTCH DEVICE FOR COMPACT POSITIVE DISPLACEMENT PUMP OF A WEARABLE DRUG DELIVERY DEVICE Final Rejection INSULET CORPORATION
17822002 METHODS AND SYSTEMS FOR MANAGING FLUID PUMP DELIVERY IMPEDIMENTS Final Rejection INSULET CORPORATION
17412684 SYSTEMS AND METHODS FOR ACTIVATING DRUG DELIVERY DEVICES Non-Final OA Insulet Corporation
18048571 SYSTEMS AND METHODS FOR PRODUCING MIXTURES Non-Final OA Boston Scientific Scimed, Inc.
17970705 SYSTEMS AND METHODS FOR PRODUCING MIXTURES Non-Final OA Boston Scientific Scimed, Inc.
18034623 CAPACITIVE SENSING FOR DRUG DELIVERY Non-Final OA Analog Devices, Inc.
17332741 COMPRESSIBLE NEEDLELESS VALVE ASSEMBLY Final Rejection CareFusion 303, Inc.
18528018 SELF-CONTAINED SPRING INSERTER FOR DRUG DELIVERY INFUSION SET Non-Final OA Becton, Dickinson and Company
17945632 Device and Method for Determining Information Related to a Medical Device Final Rejection Sanofi-Aventis Deutschland GmbH
17453601 Cap Assembly for a Medicament Final Rejection Sanofi-Aventis Deutschland GMBH
17320603 Vial Transfer and Injection Apparatus and Method Final Rejection Enable Injections, Inc.
17990196 MICRONEEDLE PATCH, MICRO NEEDLE SYSTEM AND METHOD OF FABRICATING THE SAME Non-Final OA Industry-Academic Cooperation Foundation, Yonsei University
18323117 METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR CGM-BASED PREVENTION OF HYPOGLYCEMIA VIA HYPOGLYCEMIA RISK ASSESSMENT AND SMOOTH REDUCTION INSULIN DELIVERY Non-Final OA UNIVERSITY OF VIRGINIA PATENT FOUNDATION
18039019 ARRANGEMENT FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE Non-Final OA Sanofi
18098538 THERAPEUTIC DELIVERY DEVICE Non-Final OA University of Utah Research Foundation
18206476 SHIFTING INSULIN THERAPY PARAMETERS IN TIME Non-Final OA Tandem Diabetes Care, Inc.
17715727 PUMP WITH THERAPY COACHING Non-Final OA Tandem Diabetes Care, Inc.
18304020 STEERABLE MEDICAL DEVICE, HANDLE FOR A MEDICAL DEVICE, AND METHOD FOR OPERATING A MEDICAL DEVICE Non-Final OA Boston Scientific Medical Device Limited
18515079 HEMOSTASIS VALVES AND METHODS OF USE Non-Final OA Inari Medical, Inc.
18218974 EXTENDABLE LUMEN CATHETER DEVICE Non-Final OA SCIENTIA VASCULAR, INC.
18119197 TIP-LOADED MICRONEEDLE ARRAYS FOR TRANSDERMAL INSERTION Final Rejection Carnegie Mellon University
18215420 INFUSION PUMP AND SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLLE MEDICAMENTS Final Rejection Trustees of Boston University
18339387 INTRADERMAL INJECTION DEVICE Final Rejection Inovio Pharmaceuticals, Inc.
16804707 VARIABLE CURRENT DENSITY SINGLE NEEDLE ELECTROPORATION SYSTEM AND METHOD Non-Final OA Inovio Pharmaceuticals, Inc.
18439826 CLOSED STERILE MEDICATION MIXING AND/OR ADMINISTRATION SYSTEM WITH DISINFECTION OPTIONS Non-Final OA Hyprotek, Inc.
18240189 ISOLATED WEARABLE BREAST PUMP Non-Final OA Shenzhen TPH Technology Co., Ltd.
18453618 DEVICE AND METHOD FOR DELIVERY OF A HEARING DRUG FORMULATION Non-Final OA Corti Therapeutics Pte. Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month